Patents by Inventor Matthias Wabl

Matthias Wabl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6528284
    Abstract: The present invention provides isolated SRTA-70 proteins that mediate immunoglobulin class switch recombination in antibody-producing cells, and methods of procuding such proteins. The invention further provides isolated polynucleotides encoding SRTA-70 proteins, as well as vectors and host cells comprising the polynucleotides. The invention further provides methods of using SRTA-70 proteins to identify agents that modulate immunoglobulin class switch.
    Type: Grant
    Filed: January 14, 2000
    Date of Patent: March 4, 2003
    Assignees: F. Hoffman La Roche, Ltd., The Regents of the University of California
    Inventors: Matthias Wabl, Rolf Jessberger
  • Patent number: 5885827
    Abstract: A method is provided for performing saturation mutagenesis on a target gene by exploiting the immunoglobulin hypermutation system. A target gene is cloned into an expression vector containing immunoglobulin enhancer fragments that effect hypermutation, and this construct is then transfected into an immunoglobulin mutator cell, typically of pre-B lymphocyte lineage. The target gene is permitted to hypermutate at a rate approaching that of 10.sup.-4 /bp/generation as the cells are cultured to a desired density. The variant polypeptides encoded by the hypermutated target gene can then be selected.
    Type: Grant
    Filed: January 23, 1996
    Date of Patent: March 23, 1999
    Assignee: The Regents of the Universtiy of California
    Inventors: Matthias Wabl, Jurgen Bachl